Reta~trutide
Reta~trutide
Other recommendations
Jumlah
Pesanan minimum adalah: 2 boxsPengiriman
Pemasok akan mengirim dalam 3–10 hari setelah pembayaran dikonfirmasi.
Barang akan dikirim dari United Kingdom, China pelabuhan.
Pengiriman ditawarkan dengan syarat FOB — pemasok menanggung biaya ke pelabuhan pengiriman yang ditentukan.
Pembayaran: Western Union
Sampel tersedia · $300.00/per sampel
Euromart Suppliers perlindungan pesanan
Setiap pembayaran Anda diamankan dengan enkripsi SSL ketat dan protokol perlindungan data PCI DSS
Lakukan pengembalian lokal gratis untuk produk cacat pada pembelian yang memenuhi syarat
Klaim pengembalian dana jika pesanan tidak dikirim, hilang, atau tiba dengan masalah produk
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
Other recommendations
KEY FEATURES
Therapeutic Class: Investigational peptide therapy
Mechanism of Action: Triple receptor agonist (GIP, GLP‑1, glucagon)
Primary Uses (Investigational): Obesity management, metabolic regulation, type 2 diabetes (under study)
Clinical Benefits (Trial Data):
Up to 24–25% body weight reduction in <1 year
Improved glucose metabolism and insulin sensitivity
Appetite suppression and increased energy expenditure
Status: Not FDA‑approved; currently in Phase II/III clinical trials
TECHNICAL SPECIFICATIONS
Molecular Type: Synthetic peptide (LY‑3437943)
Administration Route: Subcutaneous injection (once weekly)
Formulation: Prefilled injection pens (trial use)
Stability & Storage: Refrigerated until use; stability data under investigation
Safety Profile (Investigational):
GI side effects (nausea, diarrhea)
Risks under study: bone health, kidney complications, rapid weight loss
Regulatory Identifiers: Not yet assigned ATC code or HS classification (pending approval)
AVAILABLE CONFIGURATIONS
Format & Delivery:
Prefilled injection pens (trial formulations)
Bulk API (research supply only)
Concentration & Dosing:
Investigational fixed strengths (dose escalation in trials)
No commercial dosing yet established
Packaging & Labeling:
Clinical trial packaging only
Future potential: finished product packaging, private labeling (post‑approval)
Ratings & Reviews
From Other Suppliers
Ozempic 2 Pens 0.25mg + 0.5mg Wholesale & Retail in Europe, UK, USA, Asia
MOQ: 8 pieces71 sold
USOzempic Injection – Semaglutide Injection 025mg 0.5mg 1mg, 1 Pen
MOQ: 10 pieces31 sold
USOzempic Pens 0.25mg Wholesale & Retail in Europe, UK, USA, Asia
MOQ: 6 pieces39 sold
US
GB
